All In MedTech

Device Trial Radar · NCT07655401

Validation of a Wearable Bioimpedance Sensor for Hydration Monitoring

Validation of a Wearable Bioimpedance Sensor for Non-Invasive Monitoring of Hydration Status

Last checked: Nov 20, 2026Latest source record: Jun 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Aug 2026

Primary completion

Mar 15, 2027

Study completion Mar 31, 2027

Sponsor

Lead sponsor
Mode Sensors ASNot on our public-company list
Sponsor type
Industry
Collaborators
St. Olavs Hospital
First posted
Jun 17, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the project is to validate the performance of a wearable bioimpedance sensor (Re:Balans®) for monitoring hydration status. The study includes hospitalized patients aged 65 years or older who are admitted to the hospital with suspected dehydration. Data will be collected continuously throughout the hospital stay using one sensor placed on the back, one on the upper arm, and one on the front of the thigh. Sensor measurements will be compared with multiple reference methods for assessing hydration status, including blood tests, body weight and fluid balance charts. Agreement with these reference measures will form the basis for the performance evaluation. The anticipated benefit of the project is the validation of a novel, user-friendly, and non-invasive tool for hydration monitoring, with the aim of improving patient care, preventing complications, and reducing the need for hospital readmissions.

Conditions

  • Dehydration
  • Hypovolemia

Interventions

  • Bioimpedance sensorDevice

    Subjects will wear three bioimpedance sensors throughout their stay at the hospital

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Relative change in device output from admission to dischargeTime frame: Day 1 and day of discharge (up to 1 week)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • St. Olavs hospital

    Trondheim, Trøndelag, Norway

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.